Medically reviewed by Robert Burakoff, MD Irritable bowel syndrome (IBS) is a gastrointestinal (GI) disorder that causes ...
Constipation-dominant irritable bowel syndrome (IBS-C) is a chronic digestive condition that causes abdominal pain, bloating, ...
Method: Eighteen patients with diarrhea predominant irritable bowel syndrome (D-IBS) (eight females, 10 males aged 25–65 years; mean 42.6 years) with symptoms meeting the Rome-II criteria ...
There is currently no cure for dementia. However, there are treatments and support services that can help someone with the condition. These include drug and non-drug treatments, support, activities, ...
Conclusion: There is a significant herbal placebo response in patients with IBS. Different research locations and treatment durations are major sources of heterogeneity that may affect IBS patient ...
An expert in ulcerative colitis and Crohn disease, she has served as an investigator in multiple clinical trials evaluating therapies for the treatment of IBD. In this article, Dr Abraham discusses ...
Patients aged ≥45 years comprised the predominant age group ... highlighting the importance of drug monitoring. During the 12-week treatment period for IBS-C, diarrhea was the most frequently reported ...
Patients were subcategorized as having diarrhea-predominant IBS (IBS-D), constipation-predominant IBS (IBS-C), or alternating IBS (IBS-A) based on predominant bowel habits. Patients who had taken ...
A total of 122 participants with IBS were recruited to TrIuMPH at two sites. 62 participants with constipation predominant IBS (IBS-C ... to design and test future digestive health tests and ...
About EBX-102-02 A total of 122 participants with IBS were recruited to TrIuMPH at two sites. 62 participants with constipation predominant IBS (IBS-C) and 60 participants with diarrhoea ...
"We want to bridge the gap in accessing care and ensure that all patients, especially those in rural areas or who may struggle to access in-person care, can benefit from these effective treatments ...